SLC5A2 and familial dilated cardiomyopathy: This study aims to understand DCM's mechanisms, and the protective role of histone deacetylase inhibitors (Suberoylanilide hydroxamic acid, SAHA) and sodium glucose cotransporter 2 inhibitors (Dapagliflozin) in DCM development.